Literature DB >> 71913

Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.

J M Mishler, H Borberg, P M Emerson, R Gross.   

Abstract

1 Urinary hydroxyethyl starch (HES) concentrations were determined by the anthrone method, in four healthy normal male volunteers following three consecutive daily 500 ml infusions (total 1500 ml), in order to ascertain excretion rates under normal controlled conditions. 2 The HES was excreted at a rate of 2.57, 2.46, and 2.44 g/h during the first hour postinjection, on days 1, 2, and 3, respectively. 3 The rate during the interval 12-24 h postinjection, averaged 0.14, 0.21, and 0.10 g/h, on days 1,2, and 3, respectively. 4 In the intervals 24-72, 72-120, and 120-168 h after the third and final injection, the excretion rate was 0.07, 0.04, and 0.02 g/h, respectively. 5 Renal function, as assessed by serum creatinine and uric acid concentrations and 24 h void volumes, was normal during the entire period of observation. 6 The results indicate that HES is excreted at a similar rate following three consecutive daily infusions without evidence of renal injury.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71913      PMCID: PMC1429164          DOI: 10.1111/j.1365-2125.1977.tb00791.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  THE RENAL AND SYSTEMIC EFFECTS OF HYDROXYETHYL STARCH SOLUTION INFUSIONS.

Authors:  G P MURPHY; D E DEMAREE; J A GAGNON
Journal:  J Urol       Date:  1965-05       Impact factor: 7.450

2.  Persistence of starch derivatives and dextran when infused after hemorrhage.

Authors:  W L THOMPSON; J J BRITTON; R P WALTON
Journal:  J Pharmacol Exp Ther       Date:  1962-04       Impact factor: 4.030

3.  An experimental study of current therapeutic approaches to endotoxin shock.

Authors:  B S Evangelista; T J Green; D J Gwilt; T G Brown
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-07

4.  Clinical evaluation of a new plasma expander hydroxyethyl starch.

Authors:  W H Lee; N Cooper; M G Weidner; E S Murner
Journal:  J Trauma       Date:  1968-05

5.  Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander).

Authors:  T F Solanke
Journal:  Br Med J       Date:  1968-09-28

6.  Comparison of hydroxyethyl starch with plasma and dextrans in severe haemodilution.

Authors:  M Takaori; P Safar; S J Galla
Journal:  Can Anaesth Soc J       Date:  1968-07

7.  A clinical physiologic study of hydroxyethyl starch.

Authors:  W Metcalf; A Papadopoulos; R Tufaro; A Barth
Journal:  Surg Gynecol Obstet       Date:  1970-08

8.  Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.

Authors:  W L Thompson; T Fukushima; R B Rutherford; R P Walton
Journal:  Surg Gynecol Obstet       Date:  1970-11

9.  Use of hydroxyethyl starch solution in extensive surgical operations.

Authors:  S Gollub; D C Schechter; T Hirose; C P Bailey
Journal:  Surg Gynecol Obstet       Date:  1969-04

10.  Changes in the molecular composition of circulating hydroxyethyl starch.

Authors:  S P Farrow; M Hall; C R Ricketts
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

View more
  3 in total

Review 1.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

2.  Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.

Authors:  J M Mishler; C R Ricketts; E J Parkhouse
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

Review 3.  Clinical pharmacokinetic considerations in the use of plasma expanders.

Authors:  U Klotz; H Kroemer
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.